Garheng Kong

Investor Director & Board Member

Garheng founded HealthQuest Capital in 2012 to improve people’s lives through improving healthcare on a significant scale.

A physician, scientist, and engineer by training, Garheng has over two decades of experience investing in innovative healthcare companies with a long list of successes. He has served on the boards of 23 of HealthQuest portfolio companies, including LabCorp and Alimera Sciences. Some of his notable past successes include IPO’s with Avedro (AVDR), Castle Biosciences (CSTL), Cempra (CEMP), Alimera (ALIM), Applied Genetic Technology Corp. (AGTC), Proteon (PRTO), Histogenics (HSGX) and TransEnterix (TRXC).

Garheng received undergraduate degrees in both Chemical Engineering and Biological Sciences from Stanford, while on an athletic scholarship. He then earned a MD, PhD and MBA from Duke University, graduating #1 in his class in each instance.